Menold Daniel
- SEC CIK
- 0001705745
No open-market purchases or sales filed in the past year.
Current role at each company
- CBAY CymaBay Therapeutics, Inc.Vice President, Financeas of Jan 16, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Menold Daniel as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 (view filing) | Jan 16 | Same day | Menold DanielVice President, Finance | SSale | −10.0K | $23.58 | −$235.8K | −100.0%0 after | 10b5-1 |
| Dec 15, 2023 (view filing) | Dec 15 | Same day | Menold DanielVice President, Finance | SSale | −21.5K | $21.99 | −$472.6K | −100.0%0 after | 2 lots10b5-1 |
| Nov 17, 2023 (view filing) | Nov 15 | 2 days | Menold DanielVice President, Finance | SSale | 0 | – | $0 | –0 after | 10b5-1 |
| Oct 18, 2023 (view filing) | Oct 16 | 2 days | Menold DanielVice President, Finance | SSale | 0 | – | $0 | –0 after | 10b5-1 |
| Sep 19, 2023 (view filing) | Sep 15 | 4 days | Menold DanielVice President, Finance | SSale | 0 | – | $0 | –0 after | 2 lots10b5-1 |
| Aug 16, 2023 (view filing) | Aug 15 | 1 day | Menold DanielVice President, Finance | SSale | 0 | – | $0 | –0 after | 2 lots10b5-1 |
| Aug 11, 2023 (view filing) | Aug 9 | 2 days | Menold DanielVice President, Finance | SSale | −20.9K | $12.35 | −$258.7K | −100.0%0 after | 10b5-1 |